Plant Advanced Technologies SA (ALPAT.PA)

EUR 11.7

(-2.5%)

Total Assets Summary of Plant Advanced Technologies SA

  • Plant Advanced Technologies SA's latest annual total assets in 2023 was 14.91 Million EUR , down -12.69% from previous year.
  • Plant Advanced Technologies SA's latest quarterly total assets in 2023 FY was 14.91 Million EUR , down -12.69% from previous quarter.
  • Plant Advanced Technologies SA reported annual total assets of 17.08 Million EUR in 2022, down -0.16% from previous year.
  • Plant Advanced Technologies SA reported annual total assets of 17.1 Million EUR in 2021, down -0.92% from previous year.
  • Plant Advanced Technologies SA reported quarterly total assets of 14.91 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Plant Advanced Technologies SA reported quarterly total assets of 14.3 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Plant Advanced Technologies SA (2023 - 2012)

Historical Annual Total Assets of Plant Advanced Technologies SA (2023 - 2012)

Year Total Assets Total Assets Growth
2023 14.91 Million EUR -12.69%
2022 17.08 Million EUR -0.16%
2021 17.1 Million EUR -0.92%
2020 17.26 Million EUR 24.33%
2019 13.88 Million EUR 109139.65%
2018 12.71 Thousand EUR 29.73%
2017 9799.68 EUR 0.03%
2016 9797.16 EUR -6.17%
2015 10.44 Thousand EUR 89.55%
2014 5508.44 EUR -99.87%
2013 4.25 Million EUR 20.23%
2012 3.53 Million EUR 0.0%

Peer Total Assets Comparison of Plant Advanced Technologies SA

Name Total Assets Total Assets Difference
ABIONYX Pharma SA 14.71 Million EUR -1.38%
ABIVAX Société Anonyme 327.06 Million EUR 95.44%
Adocia SA 24.95 Million EUR 40.243%
Aelis Farma SA 26.28 Million EUR 43.256%
Biophytis S.A. 11.93 Million EUR -24.941%
Advicenne S.A. 12.4 Million EUR -20.198%
genOway Société anonyme 31.84 Million EUR 53.166%
IntegraGen SA 8 Million EUR -86.403%
Medesis Pharma S.A. 1.92 Million EUR -674.161%
Neovacs S.A. 47.53 Million EUR 68.627%
NFL Biosciences SA 3.97 Million EUR -275.581%
Quantum Genomics Société Anonyme 3.74 Million EUR -298.021%
Sensorion SA 46.49 Million EUR 67.925%
Theranexus Société Anonyme 7.23 Million EUR -106.044%
TME Pharma N.V. 2.49 Million EUR -498.672%
Valbiotis SA 33.24 Million EUR 55.146%
TheraVet SA 7.53 Million EUR -97.937%
Valerio Therapeutics Société anonyme 35.27 Million EUR 57.723%
argenx SE 4.11 Billion EUR 99.637%
BioSenic S.A. 9.55 Million EUR -56.009%
Celyad Oncology SA 16.28 Million EUR 8.409%
DBV Technologies S.A. 165.65 Million USD 90.997%
Galapagos NV 4.35 Billion EUR 99.658%
Genfit S.A. 173.87 Million EUR 91.423%
GeNeuro SA 6.31 Million EUR -136.229%
Hyloris Pharmaceuticals SA 47.68 Million EUR 68.724%
Innate Pharma S.A. 184.19 Million EUR 91.904%
Inventiva S.A. 69.13 Million EUR 78.431%
MaaT Pharma SA 42.93 Million EUR 65.263%
MedinCell S.A. 36.94 Million EUR 59.638%
Nanobiotix S.A. 93.89 Million EUR 84.118%
Onward Medical N.V. 43.62 Million EUR 65.819%
Oryzon Genomics S.A. 106.9 Million EUR 86.05%
OSE Immunotherapeutics SA 81.9 Million EUR 81.791%
Oxurion NV 6.55 Million EUR -127.678%
Pharming Group N.V. 426.33 Million EUR 96.502%
Poxel S.A. 4.82 Million EUR -209.204%
GenSight Biologics S.A. 9.08 Million EUR -64.113%
Transgene SA 45.21 Million EUR 67.019%
Financière de Tubize SA 1.92 Billion EUR 99.223%
UCB SA 15.53 Billion EUR 99.904%
Valneva SE 469.39 Million EUR 96.823%
Vivoryon Therapeutics N.V. 30.82 Million EUR 51.627%